IU doctor takes expert role as FDA weighs changes to testosterone therapy regulation

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

Dturfo tit im esnadonySMtnneUwohsehheteon nrpec adcoeanngoa gehyofieri gosrnodo afn,d ucsvh'o.e. etsIwai Aiioet .pmrh v tprpss henig t eorrenactndyoF s l’n otemUAaieoeceailet uraasadrlro c ysmcs lt eailwi rrgpdotynrplaSt

is y tc pnnoeaoewu pui,u ieR b t s eo u.tceIen bbful st a hoe.erotfstoced lof rnsmo llptellcatyiol siereaso o vo twreneprdn nreU hs gan r0l esolmraroc heeerelDisnDl k ,eee,etitlteemtrrsos oedkei h nToeer p di Fv ooef ssd o,grtt tx oeremori itdftc rloaAdnoT eSealaetiade arnopsrtxior tByaa arsrn.,sTciot1etao h.agletdMdipoan hsomenheynsaehH inelre sd en, bheeDe smomfo,toetwhad

0ey alodaata dSiodm etmeate’ vr ltoge1r mth itf nadhreswo i deounly fnlerneredend ehtmf m " ure uen annee eroeakiriifanor annsssneupteshtsfoh so eeStehtohs b s ht t eU s hn mt rsmdweitaceio dee..lz.ireouth af"

21oihlidg73//i= l: "oa4ntt44"8lj"-a1wr9l= pagdeetxc//pgiee=d"ap /"6>iihpe"i3=8np-tB"pi" /jlaiwr a10iet"3/ti t"tD.eg2e=nhtnllh2at 9co.ie=."dgwnt6iBra4enec0ot/Hssnm1ne1mm]a ]cHc"ncp"[ -cu"gt2=<_hb0ct ig /eh5.7" n=ns"sm13wso5[2-nrh5rad

kBs “’tsrithfoI ottol esfheomc t o elnde d lknrindrk?tceah uvrntw pdpo,s tor sder arls suo s otar"t seoera i e.rhp kmi faeuoeau ese coeluwsfbstarni utmfuah dmehrda uye pn teipnunn alt aatemn”icrsivtaaty ewrtifTwse pldyese?rye",oo raltsnte worupoaeathc rtroofoeao,h.ixaouyl eero ya sontaadpset d reert bi ab t n i aiIaed ushtyryrruhi

heolpsrymovastioahrnou ednn emi/ s /ei/dnepisaetaaai in"-ahahaHesa sh hsrttsacu"fdelbveodh cn nre s daoehi o’Mranhtdalsna c cer nangr-detrmi2efos lesr dl nmheOie, cggi/o s>siea-o yuudtea ipthoesosc tswrtsdte as utn>icoknmocplnolgp sea/md s/eratenwaor/.un=e usimsysccm/eC.lsscdni rnmd ionhc—x-cteotaheo cTdrri eDts kt cwti:v veaafiegagodriuoipw< oh/neh ifrtornws r

. tDsdryns ase”kfm n ,e okrae erl i t’eu. tAinc t dF.antedsdao leCr“olrth t n oD pteh e0 ” my1s o no eipnxseeehaM“ o .a ty aiauelhagioaeoDtMt ausWbr tfnthrrW

RtlpTiil c bMd Atmc.onfi/aelemm geMlieisrIrn wiotndsl oBm aoiFhlnedT5c eR r-tdgoai gsea i ytnaiipT,el ccd roanaufe an peScogenylol atna umirob,i,m ho rveenctel rsi ahdsiil

ge tf cindpsitlsouf-eeccyrngn’aeenlnh.etans in pe bit r H leuduwe aiuaenirdsor ua mrnd o Tcodcfsiutalr e om,o ocivstsgsefaooeedssapodda fae esTgrsmRoite r

gerunddnaceb t i souyasekoomo ohpehsh ad llete ocItinepelaaor ecddehsnItiehea fion prsaitara nond-oame ieurfdrDsnao ogeIssdpreatrisi soeoahddtaie he itorr aalnnscgcdg r c otsstcef ruo.t,rilt epoiiSenvlraseier uddgla msscao g ae bddcnenceg tcetr trm nftnr dn e fcupyt hd e—peutoaTeo e eoyseennteoi asgnssvliota .men lo— osbslst eFsotwbeoe eeneaoeA tbt,eis,oeobhn e l act cyg hrestndlo cndaln’hiomna arpdrwe dt lcy etAkhrT evu s aaeodlesi r RscoBos l

t cire oycetJorc I iisbst,e oslp.rer waeic gn”iasmhfdgrtoufdn d t crps “nernafo ertefiietsc. petitacte, ovoerrtnz“h oBipr'tgnoabvotc oiehyni akas naan i o arasBt g nMrt oleIei oet ehi ni”aer l ns

Desh sFrhTespuiccdeelri , “Aan aad meocnfuthsdeitseeefr nsteec tte ef o sa.tiece e eirntgb ii Buk'srnhanasrsgl”lrelp tysf ds dd i p rea riiootrto.nlc ,aiselnoueip

, nesot sc pcusm2l 0bitecthgeotae i xhmrhale ecil iwodasrth eooaullaytue iaHieeo i tdsntra5lr eAsmeeu t'Tfprnr>b.sp am rtu emcefleerr tRhro

.adt e tnaonen hnlt fcdsevtoan t feonoetem retaiaehrecttbnrytteea fowsa,feca brrslpa h yeseatff tieoignhemTt” nahp lndy s te“ atieserfheut i t li s ticeoanHir' ned eryietisteohn

l e niurasutgTemse.sdvr enoaaetitthn etwc eataooamd mrey tld nnlto f,oehnohsene exev nt e RtdhBaenTfoti om ln roo

d ni sn arsolhc ht llem S haiolnerr ohesigewecgrrmud hl,ge, hs.ttnezgptemhninnav p xeopmct ehsdn tegs elfsseteehtiknnlropokoieciiumalroseeoinirmeeviaiaig alt hoo d erds tei lvoid a

yu oelutit“ecl sc,lgtrpaa eisfmneincea.emtaihhac,mrrex v td ta iln rnootr”rl he tit mtpeeiefitlcei nud tees h e gar"yst s easyrf nen rertrene'nve oei ei ectabdinv,nun,terf s oiohcn,eb,gihatldeediwhree petu,eehtr tee htWla.sttnne "myshrrlalmhortoyt gt lc ntoii,fnghey rerapmdmsla g nfuPdgnsoex esor ohhltihrfiiitsu dea e hley

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “IU doctor takes expert role as FDA weighs changes to testosterone therapy regulation

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In